Mechanistically, HOXC8 functioned as a transcriptional activator of transforming growth‐factor beta signaling pathway, finally mediating increased proliferation, anchorage‐independent growth and migration of NSCLC, as well as chemoresistance and antiapoptosis in NSCLC.64 Here, HOXC8 is linked to non-small cell lung carcinoma.